D-1287-2014 Class II Terminated
FDA drug recall D-1287-2014 was initiated by AbbVie Inc on Mar 10, 2014 and is designated Class II. Reason for recall: Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device. The recall status is terminated (terminated Jun 22, 2016). Affected quantity: 7362 kits.
Recall details
- Product Type
- Drugs
- Report Date
- May 7, 2014
- Initiation Date
- Mar 10, 2014
- Termination Date
- Jun 22, 2016
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 7362 kits
Product description
Lupron Depot (Leuprolide Acetate for Depot Suspension) Single Dose Administration Kit with prefilled dual-chamber syringe, 22.5 mg for 3-month administration, Rx only, Manufactured for: AbbVie Inc., North Chicago, IL 60064; by: Takeda Pharmaceutical Company Limited, Osaka, Japan 540-8645; NDC 0074-3346-03, UPC 3 00743 34603 9.
Reason for recall
Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.
Distribution pattern
Nationwide and Puerto Rico
Code information
Lot #: 1014204, Exp 10/11/15; 1014485, Exp 12/11/16; and 1015007, Exp 12/06/16
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1287-2014
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for AbbVie Inc? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.